Financial Ratios Scholar Rock Holding Corporation

Stocks

SRRK

US80706P1030

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2026-08-07 EDT			5-day change	1st Jan Change
52.92 ^USD	+0.53%		+11.89%	+20.14%

08-07	Scholar Rock drops Novo Nordisk facility from marketing application for muscle weakness drug	RE
08-07	Scholar Rock Holdings Pulls Novo Nordisk Facility From Drug Application After FDA Flag	DJ

1ff715d6965cc0d22a292543d472.u9GMYS2w8aw0ltCDiHBfqJL4GLM0HrYMQ-2Eusr5QHM.5L_2FxjFiZly06nH0gIt8vyMU8QFS-FWGaG1if2pHwuN5No-SsSU4nH3iQ

Published financial data: SCHOLAR ROCK HOLDING CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	18.82M	33.19M	-	-	-
Total Revenues	18.82M	33.19M	-	-	-
Cost of Goods Sold, Total	108M	123M	122M	185M	208M
Gross Profit	-89.65M	-89.85M	-122M	-185M	-208M
Selling General & Admin Expenses, Total	40.27M	42.62M	49.4M	67.5M	176M
Other Operating Expenses, Total	40.27M	42.62M	49.4M	67.5M	176M
Operating Income	-130M	-132M	-171M	-252M	-385M
Interest Expense, Total	-	-	-6.5M	-6.84M	-6.89M
Interest And Investment Income	-	-	-	12.68M	13.9M
Net Interest Expenses	-	-	-6.5M	5.84M	7.01M
Other Non Operating Income (Expenses)	-1.88M	-132K	12.01M	-85K	-301K
EBT, Excl. Unusual Items	-132M	-133M	-166M	-246M	-378M
Restructuring Charges	-	-1.9M	-	-	-
EBT, Incl. Unusual Items	-132M	-135M	-166M	-246M	-378M
Earnings From Continuing Operations	-132M	-135M	-166M	-246M	-378M
Net Income to Company	-132M	-135M	-166M	-246M	-378M
Net Income - (IS)	-132M	-135M	-166M	-246M	-378M
Net Income to Common Incl Extra Items	-132M	-135M	-166M	-246M	-378M
Net Income to Common Excl. Extra Items	-132M	-135M	-166M	-246M	-378M
Per Share Items
Net EPS - Basic	-3.59	-2.26	-2.18	-2.63	-3.48
Basic EPS - Continuing Operations	-3.59	-2.26	-2.18	-2.63	-3.48
Basic Weighted Average Shares Outstanding	36.71M	59.61M	75.98M	93.82M	108M
Net EPS - Diluted	-3.59	-2.26	-2.18	-2.63	-3.48
Diluted EPS - Continuing Operations	-3.59	-2.26	-2.18	-2.63	-3.48
Diluted Weighted Average Shares Outstanding	36.71M	59.61M	75.98M	93.82M	108M
Normalized Basic EPS	-2.24	-1.39	-1.36	-1.64	-2.18
Normalized Diluted EPS	-2.24	-1.39	-1.36	-1.64	-2.18
Supplemental Items
EBITDA	-127M	-129M	-168M	-250M	-383M
EBITA	-130M	-132M	-171M	-252M	-385M
EBIT	-130M	-132M	-171M	-252M	-385M
EBITDAR	-116M	-121M	-160M	-242M	-375M
Normalized Net Income	-82.37M	-82.88M	-104M	-154M	-236M
Interest on Long-Term Debt	2.1M	4.7M	6.5M	6.6M	6.3M
Supplemental Operating Expense Items
General and Administrative Expenses	40.27M	42.62M	49.4M	67.5M	176M
Research And Development Expense From Footnotes	108M	124M	122M	185M	208M
Net Rental Expense, Total	10.9M	8.06M	8.44M	8.45M	8.39M
Imputed Operating Lease Interest Expense	-	-	6.69M	7.28M	5.32M
Imputed Operating Lease Depreciation	-	-	1.75M	1.17M	3.07M
Stock-Based Comp., COGS (Total)	10.18M	12.93M	11.2M	16M	20.68M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	12.97M	14.78M	15.94M	20.63M	54.92M
Total Stock-Based Compensation	23.15M	27.7M	27.14M	36.63M	75.6M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	213M	103M	102M	178M	324M
Short Term Investments	40.16M	212M	178M	259M	44.04M
Total Cash And Short Term Investments	253M	315M	280M	437M	368M
Accounts Receivable, Total	-	-	-	-	-
Other Receivables	-	-	1.08M	2.15M	2.8M
Total Receivables	-	-	1.08M	2.15M	2.8M
Prepaid Expenses	12.32M	12.66M	7.18M	11.74M	14.78M
Total Current Assets	265M	328M	288M	451M	385M
Gross Property Plant And Equipment	42.3M	36.16M	27.34M	31.62M	26.96M
Accumulated Depreciation	-7.29M	-10.23M	-11.33M	-13.22M	-14.88M
Net Property Plant And Equipment	35.01M	25.93M	16.02M	18.4M	12.09M
Long-term Investments	-	-	-	-	-
Other Long-Term Assets, Total	4.12M	4.22M	6.82M	5.35M	7.04M
Total Assets	304M	358M	311M	475M	404M
Liabilities
Accounts Payable, Total	4.43M	3.99M	3.46M	10.1M	10.3M
Accrued Expenses, Total	17.43M	24.32M	20.45M	31.07M	39.57M
Short-term Borrowings	1.58M	-	1.33M	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	7.41M	7.85M	7.41M	5.77M	5.55M
Unearned Revenue Current, Total	33.19M	-	-	-	-
Other Current Liabilities	254K	222K	85K	-	-
Total Current Liabilities	64.3M	36.39M	32.74M	46.94M	55.42M
Long-Term Debt	48.42M	49.74M	48.68M	50.15M	99.71M
Long-Term Leases	19.65M	11.8M	4.39M	9.21M	3.66M
Unearned Revenue Non Current	-	-	-	-	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	132M	97.93M	85.82M	106M	159M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	35K	52K	76K	94K	108K
Additional Paid In Capital	548M	772M	901M	1.29B	1.55B
Retained Earnings	-376M	-511M	-676M	-923M	-1.3B
Comprehensive Income and Other	-35K	-884K	92K	160K	94K
Total Common Equity	172M	260M	225M	369M	245M
Total Equity	172M	260M	225M	369M	245M
Total Liabilities And Equity	304M	358M	311M	475M	404M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	35.3M	51.99M	77.87M	94.68M	115M
ECS Total Common Shares Outstanding	35.21M	51.67M	75.98M	93.82M	108M
Book Value / Share	4.89	5.04	2.96	3.93	2.26
Tangible Book Value	172M	260M	225M	369M	245M
Tangible Book Value Per Share	4.89	5.04	2.96	3.93	2.26
Total Debt	77.06M	69.4M	61.82M	65.13M	109M
Net Debt	-176M	-246M	-218M	-372M	-259M
Debt Equivalent Oper. Leases	87.18M	64.44M	67.49M	67.62M	67.11M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	11.65M	12.46M	12.34M	12.37M	12.93M
Full Time Employees	145	114	150	196	289

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-132M	-135M	-166M	-246M	-378M
Depreciation & Amortization - CF	2.63M	2.99M	2.84M	1.94M	1.66M
Depreciation & Amortization, Total	2.63M	2.99M	2.84M	1.94M	1.66M
Amortization of Deferred Charges, Total - (CF)	335K	720K	274K	253K	423K
(Gain) Loss From Sale Of Asset	24K	33K	11K	-	-
(Gain) Loss on Sale of Investments - (CF)	918K	-2.14M	-6.22M	-5.29M	-3.99M
Stock-Based Compensation (CF)	23.15M	27.7M	27.14M	36.63M	75.6M
Other Operating Activities, Total	6.4M	6.9M	7.13M	5.22M	5.26M
Change In Accounts Receivable	-	-	-	-	-
Change In Accounts Payable	1.02M	-251K	-529K	6.63M	208K
Change in Unearned Revenues	-18.82M	-33.19M	-	-	-
Change in Other Net Operating Assets	-10.64M	-945K	-10.08M	-36K	-1.26M
Cash from Operations	-127M	-133M	-145M	-201M	-300M
Capital Expenditure	-5.25M	-1.06M	-71K	-98K	-602K
Sale of Property, Plant, and Equipment	-	-	13K	-	-
Investment in Marketable and Equity Securities, Total	140M	-171M	41.2M	-75.96M	219M
Cash from Investing	134M	-172M	41.14M	-76.06M	219M
Long-Term Debt Issued, Total	24.98M	-	-	-	74.66M
Total Debt Issued	24.98M	-	-	-	74.66M
Long-Term Debt Repaid, Total	-	-975K	-	-125K	-25.52M
Total Debt Repaid	-	-975K	-	-125K	-25.52M
Issuance of Common Stock	19.99M	196M	103M	353M	179M
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-20K	-	3K	-	-
Cash from Financing	44.95M	195M	103M	353M	228M
Foreign Exchange Rate Adjustments	-	-	-	-	-2K
Net Change in Cash	52.48M	-110M	-1.51M	76.02M	147M
Supplemental Items
Cash Interest Paid	2.08M	4.37M	6.4M	6.62M	6.07M
Levered Free Cash Flow	-51.17M	-79.56M	-81.06M	-112M	-163M
Unlevered Free Cash Flow	-51.51M	-80.28M	-77.28M	-108M	-159M
Change In Net Working Capital	-9.16M	27.11M	131K	-11.53M	-5.01M
Net Debt Issued / Repaid	24.98M	-975K	-	-125K	49.14M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-23.44	-24.99	-32	-40.09	-54.69
Return on Total Capital	-28.64	-28.61	-34.72	-43.71	-61
Return On Equity %	-60.9	-62.22	-68.3	-82.95	-123.08
Return on Common Equity	-60.9	-62.22	-68.3	-82.95	-123.08
Margin Analysis
Gross Profit Margin %	-476.47	-270.69	-	-	-
SG&A Margin	214.01	128.4	-	-	-
EBITDA Margin %	-676.52	-390.09	-	-	-
EBITA Margin %	-690.48	-399.09	-	-	-
EBIT Margin %	-690.48	-399.09	-	-	-
Income From Continuing Operations Margin %	-700.46	-405.21	-	-	-
Net Income Margin %	-700.46	-405.21	-	-	-
Net Avail. For Common Margin %	-700.46	-405.21	-	-	-
Normalized Net Income Margin	-437.79	-249.68	-	-	-
Levered Free Cash Flow Margin	-271.97	-239.7	-	-	-
Unlevered Free Cash Flow Margin	-273.75	-241.87	-	-	-
Asset Turnover
Asset Turnover	0.05	0.1	-	-	-
Fixed Assets Turnover	0.5	1.09	-	-	-
Short Term Liquidity
Current Ratio	4.13	9.01	8.8	9.61	6.95
Quick Ratio	3.93	8.67	8.58	9.36	6.68
Operating Cash Flow to Current Liabilities	-1.97	-3.65	-4.44	-4.28	-5.41
Average Days Payable Outstanding	13.2	12.5	11.17	13.45	17.86
Long Term Solvency
Total Debt/Equity	44.78	26.67	27.45	17.67	44.37
Total Debt / Total Capital	30.93	21.05	21.54	15.01	30.73
LT Debt/Equity	39.56	23.65	23.57	16.1	42.11
Long-Term Debt / Total Capital	27.32	18.67	18.49	13.68	29.17
Total Liabilities / Total Assets	43.48	27.34	27.59	22.38	39.28
EBIT / Interest Expense	-	-	-26.35	-36.87	-55.8
EBITDA / Interest Expense	-	-	-24.62	-35.35	-54.34
(EBITDA - Capex) / Interest Expense	-	-	-24.63	-35.36	-54.43
Total Debt / EBITDA	-0.66	-0.57	-0.39	-0.27	-0.29
Net Debt / EBITDA	1.51	2.03	1.36	1.54	0.69
Total Debt / (EBITDA - Capex)	-0.63	-0.57	-0.39	-0.27	-0.29
Net Debt / (EBITDA - Capex)	1.45	2.01	1.36	1.54	0.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	22.16	76.41	-	-	-
Gross Profit, 1 Yr. Growth %	52.84	0.22	35.67	51.39	12.94
EBITDA, 1 Yr. Growth %	49.08	1.72	30.09	48.48	53.12
EBITA, 1 Yr. Growth %	49.54	1.96	29.31	47.15	52.6
EBIT, 1 Yr. Growth %	49.54	1.96	29.31	47.15	52.6
Earnings From Cont. Operations, 1 Yr. Growth %	52.4	2.05	23.26	48.56	53.45
Net Income, 1 Yr. Growth %	52.4	2.05	23.26	48.56	53.45
Normalized Net Income, 1 Yr. Growth %	52.4	0.61	25.03	48.56	53.45
Diluted EPS Before Extra, 1 Yr. Growth %	27.58	-37.15	-3.29	20.3	32.74
Net Property, Plant and Equip., 1 Yr. Growth %	-13.31	-25.94	-38.22	14.91	-34.33
Total Assets, 1 Yr. Growth %	-21.6	17.65	-13.16	52.69	-14.88
Tangible Book Value, 1 Yr. Growth %	-34.01	51.23	-13.46	63.68	-33.41
Common Equity, 1 Yr. Growth %	-34.01	51.23	-13.46	63.68	-33.41
Cash From Operations, 1 Yr. Growth %	110.36	4.66	9.44	38.37	49.31
Capital Expenditures, 1 Yr. Growth %	28.38	-79.73	-93.33	38.03	514.29
Levered Free Cash Flow, 1 Yr. Growth %	223.94	55.48	-1.74	37.36	45.78
Unlevered Free Cash Flow, 1 Yr. Growth %	224.86	55.86	-3.75	39.16	47.61
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-4.18	46.8	-	-	-
Gross Profit, 2 Yr. CAGR %	63.04	23.76	16.61	43.32	30.76
EBITDA, 2 Yr. CAGR %	54.63	23.14	15.04	38.98	50.78
EBITA, 2 Yr. CAGR %	54.34	23.48	14.82	37.94	49.85
EBIT, 2 Yr. CAGR %	54.34	23.48	14.82	37.94	49.85
Earnings From Cont. Operations, 2 Yr. CAGR %	60.76	24.71	12.16	35.32	50.98
Net Income, 2 Yr. CAGR %	60.76	24.71	12.16	35.32	50.98
Normalized Net Income, 2 Yr. CAGR %	60.76	23.83	12.16	36.29	50.98
Diluted EPS Before Extra, 2 Yr. CAGR %	39.23	-10.45	-22.04	7.86	26.37
Net Property, Plant and Equip., 2 Yr. CAGR %	101.54	-19.87	-32.36	-15.75	-13.13
Total Assets, 2 Yr. CAGR %	24.51	-3.96	1.08	15.15	14.01
Tangible Book Value, 2 Yr. CAGR %	23.46	-0.1	14.4	19.02	4.4
Common Equity, 2 Yr. CAGR %	23.46	-0.1	14.4	19.02	4.4
Cash From Operations, 2 Yr. CAGR %	41.73	48.38	7.02	23.06	43.74
Capital Expenditures, 2 Yr. CAGR %	29.8	-48.98	-88.37	-69.65	191.18
Levered Free Cash Flow, 2 Yr. CAGR %	-1.15	124.42	25.86	16.28	41.51
Unlevered Free Cash Flow, 2 Yr. CAGR %	-0.83	125.02	22.48	15.73	43.32
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	17.44	-	-	-
Gross Profit, 3 Yr. CAGR %	35.16	38.63	27.61	27.21	32.38
EBITDA, 3 Yr. CAGR %	36.65	34.48	25.42	25.25	43.55
EBITA, 3 Yr. CAGR %	36.85	34.42	25.39	24.72	42.66
EBIT, 3 Yr. CAGR %	36.85	34.42	25.39	24.72	42.66
Earnings From Cont. Operations, 3 Yr. CAGR %	38.76	38.16	24.22	23.17	41.11
Net Income, 3 Yr. CAGR %	38.76	38.16	24.22	23.17	41.11
Normalized Net Income, 3 Yr. CAGR %	38.76	37.51	24.22	23.17	41.78
Diluted EPS Before Extra, 3 Yr. CAGR %	4.45	6.8	-8.13	-9.91	15.59
Net Property, Plant and Equip., 3 Yr. CAGR %	122.22	44.36	-26.53	-19.29	-22.46
Total Assets, 3 Yr. CAGR %	18.85	22.18	-7.13	15.98	4.12
Tangible Book Value, 3 Yr. CAGR %	17.3	32.1	-4.77	28.91	-1.93
Common Equity, 3 Yr. CAGR %	17.3	32.1	-4.77	28.91	-1.93
Cash From Operations, 3 Yr. CAGR %	72.8	28.11	34.06	16.59	31.25
Capital Expenditures, 3 Yr. CAGR %	52.08	-30.1	-74.1	-73.47	-17.29
Levered Free Cash Flow, 3 Yr. CAGR %	200.05	14.96	72.48	29.66	25.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	200.7	15.3	69.54	27.81	25.51
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	118.36	-	-	-	-
Gross Profit, 5 Yr. CAGR %	49.27	35.13	27.41	40.49	28.86
EBITDA, 5 Yr. CAGR %	52.1	39.67	27.56	36.26	35.01
EBITA, 5 Yr. CAGR %	51.63	39.55	27.57	35.82	34.66
EBIT, 5 Yr. CAGR %	51.63	39.55	27.57	35.82	34.66
Earnings From Cont. Operations, 5 Yr. CAGR %	52.07	40.02	27.44	37.02	34.31
Net Income, 5 Yr. CAGR %	52.07	40.02	27.44	37.02	34.31
Normalized Net Income, 5 Yr. CAGR %	52.07	39.62	27.44	37.02	34.31
Diluted EPS Before Extra, 5 Yr. CAGR %	-18.7	-31.8	-7.08	7.23	4.37
Net Property, Plant and Equip., 5 Yr. CAGR %	70.49	64.07	38.09	16.39	-21.44
Total Assets, 5 Yr. CAGR %	56.16	42.18	11.39	19.32	0.81
Tangible Book Value, 5 Yr. CAGR %	41.79	37.2	16.13	26.7	-1.2
Common Equity, 5 Yr. CAGR %	41.79	37.2	16.13	26.7	-1.2
Cash From Operations, 5 Yr. CAGR %	52.96	43.59	42.67	26.06	37.85
Capital Expenditures, 5 Yr. CAGR %	45.89	24.13	-45.61	-49.93	-31.83
Levered Free Cash Flow, 5 Yr. CAGR %	-	44.54	111.97	16.33	59.41
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	44.8	109.95	15.48	58.53